WilmerHale has advised PAQ Therapeutics. PAQ Therapeutics, a clinical-stage oncology biotechnology company, has announced the closing of a Series B extension that brings the company’s total...
PAQ Therapeutics Closes Series B Extension, Totaling $77 Million to Advance KRAS Degrader Therapies
Terns Pharmaceuticals Completes $747.5 Million Public Offering of Common Stock
Wilmer Cutler Pickering Hale and Dorr has advised Terns Pharmaceuticals. Davis Polk has advised the representative of the underwriters. Terns Pharmaceuticals, Inc., a clinical-stage oncology company...
Trevi Therapeutics Issues $115 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Trevi Therapeutics, Inc., and Covington & Burling advised the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company,...
Akamai’s $1.725 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and DLA Piper advised Akamai Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers....
Strategy’s $722.5 Million Preferred Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Strategy in the offering. Strategy, formerly MicroStrategy Incorporated d/b/a Strategy, the world’s first and largest Bitcoin Treasury Company, announced...
Beam Therapeutics’ $500 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Beam Therapeutics Inc., and Davis Polk & Wardwell advised the underwriters in the offering. Beam Therapeutics Inc. (Nasdaq: BEAM)...
KALA BIO’s $10.75 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr represented KALA BIO, Inc. in the transaction. KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company, announced it had entered into...
Trevi Therapeutics’ $50 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
MicroStrategy Incorporated’s $3 Billion Convertible Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised Barclays Capital, Inc., as representatives of the initial...
MicroStrategy Incorporated’s $21 Billion At-the-Market Equity Offering
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
MicroStrategy Incorporated’s $1.01 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
Medtronic’s €3.0 Billion Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...